Dipeptidyl Peptidase 4 Inhibitors
Renal Drug Excretion: Tubular Secretion
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Zhengwei Zhou1,2, Shuai Wang1,2, Tianling Feng1,2
1Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Changle Road 68, Nanjing 210006, P. R. China.
New Exendin-4 nanodevices effectively target insulinoma with reduced kidney accumulation. These novel nanoparticles show significant tumor suppression, offering a promising advancement in cancer therapy and diagnostics.
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: